BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 19524413)

  • 1. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of artificial neural networks to predict virological response to combination HIV therapy.
    Larder B; Wang D; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; Monforte AD; Torti C; Zazzi M; Lane C
    Antivir Ther; 2007; 12(1):15-24. PubMed ID: 17503743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool.
    Revell AD; Wang D; Boyd MA; Emery S; Pozniak AL; De Wolf F; Harrigan R; Montaner JS; Lane C; Larder BA;
    AIDS; 2011 Sep; 25(15):1855-63. PubMed ID: 21785323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.
    De Luca A; Vendittelli M; Baldini F; Di Giambenedetto S; Trotta MP; Cingolani A; Bacarelli A; Gori C; Perno CF; Antinori A; Ulivi G
    Antivir Ther; 2004 Aug; 9(4):583-93. PubMed ID: 15456090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.
    Van Laethem K; De Luca A; Antinori A; Cingolani A; Perna CF; Vandamme AM
    Antivir Ther; 2002 Jun; 7(2):123-9. PubMed ID: 12212924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.
    Prosperi MC; Altmann A; Rosen-Zvi M; Aharoni E; Borgulya G; Bazso F; Sönnerborg A; Schülter E; Struck D; Ulivi G; Vandamme AM; Vercauteren J; Zazzi M;
    Antivir Ther; 2009; 14(3):433-42. PubMed ID: 19474477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.
    Ziermann R; Celis L; Derdelinckx I; Lambert C; Veeck J; Rizzo MG; Vanderborght B; Zissis G; Clumeck N; Fransen K; Vaira D; Hendricks D; Van Laethem K; Vandamme AM; Schmit JC; Knechten H; De Luca A; Louwagie J; Segers P; De Boeck K; Pottel H; De Brauwer A; Hulstaert F
    J Clin Virol; 2004 Dec; 31 Suppl 1():S7-15. PubMed ID: 15567089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar study.
    Flandre P; Marcelin AG; Pavie J; Shmidely N; Wirden M; Lada O; Bernard MC; Molina JM; Calvez V
    Antivir Ther; 2005; 10(4):479-87. PubMed ID: 16038473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences of nine drug resistance interpretation systems in predicting short-term therapy outcomes of treatment-experienced HIV-1 infected patients: a retrospective observational cohort study.
    Helm M; Walter H; Ehret R; Schmit JC; Kurowski M; Knechten H; Korn K; Braun P; Schmidt B
    Eur J Med Res; 2007 Jun; 12(6):231-42. PubMed ID: 17666312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.
    Deforche K; Cozzi-Lepri A; Theys K; Clotet B; Camacho RJ; Kjaer J; Van Laethem K; Phillips A; Moreau Y; Lundgren JD; Vandamme AM;
    Antivir Ther; 2008; 13(3):399-407. PubMed ID: 18572753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the comparison of artificial network and interpretation systems based on genotype resistance mutations in HIV-1-infected patients.
    Flandre P; Costagliola D
    AIDS; 2006 Oct; 20(16):2118-20. PubMed ID: 17053360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy.
    Schmidt B; Walter H; Zeitler N; Korn K
    AIDS Rev; 2002; 4(3):148-56. PubMed ID: 12416449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.
    Marcelin AG; Flandre P; Molina JM; Katlama C; Yeni P; Raffi F; Antoun Z; Ait-Khaled M; Calvez V
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4251-7. PubMed ID: 18852278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.
    Altmann A; Sing T; Vermeiren H; Winters B; Van Craenenbroeck E; Van der Borght K; Rhee SY; Shafer RW; Schülter E; Kaiser R; Peres Y; Sönnerborg A; Fessel WJ; Incardona F; Zazzi M; Bacheler L; Van Vlijmen H; Lengauer T
    Antivir Ther; 2009; 14(2):273-83. PubMed ID: 19430102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures.
    Winters B; Van Craenenbroeck E; Van der Borght K; Lecocq P; Villacian J; Bacheler L
    J Virol Methods; 2009 Dec; 162(1-2):101-8. PubMed ID: 19654022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.
    Zazzi M; Prosperi M; Vicenti I; Di Giambenedetto S; Callegaro A; Bruzzone B; Baldanti F; Gonnelli A; Boeri E; Paolini E; Rusconi S; Giacometti A; Maggiolo F; Menzo S; De Luca A;
    J Antimicrob Chemother; 2009 Sep; 64(3):616-24. PubMed ID: 19620134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors.
    Fox ZV; Geretti AM; Kjaer J; Dragsted UB; Phillips AN; Gerstoft J; Staszewski S; Clotet B; von Wyl V; Lundgren JD
    AIDS; 2007 Oct; 21(15):2033-42. PubMed ID: 17885293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.
    Assoumou L; Brun-Vézinet F; Cozzi-Lepri A; Kuritzkes D; Phillips A; Zolopa A; Degruttola V; Miller V; Costagliola D;
    J Infect Dis; 2008 Aug; 198(4):470-80. PubMed ID: 18598191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems.
    Pasomsub E; Sukasem C; Sungkanuparph S; Kijsirikul B; Chantratita W
    Jpn J Infect Dis; 2010 Mar; 63(2):87-94. PubMed ID: 20332568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.